Research Project

Project Title:	A Phase 3, Randomized, Double-blinded, Placebo-controlled, multicenter study to evaluate the efficacy and safety of Pegcetacoplan in patients with primary C3 glomerulopathy or Immuno-Complex Membranoproliferative Glomerulonephritis
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	A Phase 3, Randomized, Double-blinded, Placebo-controlled, multicenter study to evaluate the efficacy and safety of Pegcetacoplan in patients with primary C3 glomerulopathy or Immuno-Complex Membranoproliferative Glomerulonephritis
Lead principal investigator(s):	Gaetano La Manna, Bologna
Co-investigator(s):	Olga Baraldi, Bologna Agnieszka Przygocka, Bologna Serena Speciale, Bologna Gema Ariceta, Barcelona
Project Period:	07/2022 - 12/2026
Sponsors:	Industry